News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
162 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24639)
Month
January (2434)
February (2868)
March (3029)
April (3116)
May (3356)
June (2727)
July (2287)
August (2492)
September (2330)
Day
1 (180)
2 (176)
3 (167)
4 (36)
6 (28)
7 (20)
8 (209)
9 (212)
10 (153)
11 (45)
13 (31)
14 (133)
15 (141)
16 (97)
17 (129)
18 (39)
20 (21)
21 (93)
22 (125)
23 (162)
24 (113)
25 (20)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
Press Releases
Positive interim data shows Roche’s sefaxersen significantly reduces proteinuria in people with IgA nephropathy (IgAN)
September 23, 2026
·
9 min read
Press Releases
Positive Interim Data Shows Genentech’s Sefaxersen Significantly Reduces Proteinuria in People With IgA Nephropathy (IgAN)
September 23, 2026
·
6 min read
Press Releases
Ionis announces positive interim data from partner Roche’s Phase 3 IMAgINATION study in IgA nephropathy (IgAN)
September 23, 2026
·
6 min read
Press Releases
OSE Immunotherapeutics Announces Presentation of Combi-TED Phase 2 Topline Results of Tedopi® in Non-Small Cell Lung Cancer at the ESMO 2026 Meeting
September 23, 2026
·
4 min read
Press Releases
Sensorion Reports 2026 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report
September 23, 2026
·
13 min read
Press Releases
Anaconda Biomed Secures $56 Million Financing from New and Existing Investors
September 23, 2026
·
3 min read
Press Releases
Engitix appoints Sonia Quaratino, MD, PhD as EVP Chief Medical Officer as its ECM pipeline moves toward clinical development
September 23, 2026
·
4 min read
Press Releases
Boehringer Ingelheim and AWARE launch new Stop Rabies project in Zimbabwe to help protect dogs and communities
September 23, 2026
·
4 min read
Press Releases
Actimed Therapeutics Completes Recruitment for PROACT Phase 2a Study Evaluating S-pindolol benzoate (ACM 001.1) in Obese Adults During and After Semaglutide Therapy
September 23, 2026
·
4 min read
Press Releases
Scarlet Therapeutics Secures DARPA Agreement to Develop Adaptive Smart Red Blood Cells
September 23, 2026
·
3 min read
Previous
5 of 17
Next
